Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 3
1984 2
1985 3
1986 1
1988 2
1989 2
1991 1
1994 3
1995 4
1996 2
1997 2
1998 2
1999 1
2000 2
2001 2
2002 4
2003 3
2004 3
2005 1
2006 5
2007 1
2009 4
2010 2
2011 4
2012 3
2013 5
2014 4
2015 1
2016 3
2017 3
2018 1
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

76 results
Results by year
Filters applied: . Clear all
Page 1
Cisplatin increases PD-L1 expression and optimizes immune check-point blockade in non-small cell lung cancer.
Fournel L, Wu Z, Stadler N, Damotte D, Lococo F, Boulle G, Ségal-Bendirdjian E, Bobbio A, Icard P, Trédaniel J, Alifano M, Forgez P. Fournel L, et al. Among authors: Forgez P. Cancer Lett. 2019 Nov 1;464:5-14. doi: 10.1016/j.canlet.2019.08.005. Epub 2019 Aug 9. Cancer Lett. 2019. PMID: 31404614
Expression of neurotensin receptor 1 in endometrial adenocarcinoma is correlated with histological grade and clinical outcome.
Agopiantz M, Forgez P, Casse JM, Lacomme S, Charra-Brunaud C, Clerc-Urmès I, Morel O, Bonnet C, Guéant JL, Vignaud JM, Gompel A, Gauchotte G. Agopiantz M, et al. Among authors: Forgez P. Virchows Arch. 2017 Oct;471(4):521-530. doi: 10.1007/s00428-017-2215-y. Epub 2017 Aug 24. Virchows Arch. 2017. PMID: 28836043
Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody.
Wu Z, Fournel L, Stadler N, Liu J, Boullier A, Hoyeau N, Fléjou JF, Duchatelle V, Djebrani-Oussedik N, Agopiantz M, Ségal-Bendirdjian E, Gompel A, Alifano M, Melander O, Trédaniel J, Forgez P. Wu Z, et al. Among authors: Forgez P. Cancer Lett. 2019 Mar 1;444:147-161. doi: 10.1016/j.canlet.2018.12.007. Epub 2018 Dec 21. Cancer Lett. 2019. PMID: 30583074
Preclinical Evaluation of 68Ga-DOTA-NT-20.3: A Promising PET Imaging Probe To Discriminate Human Pancreatic Ductal Adenocarcinoma from Pancreatitis.
Prignon A, Provost C, Alshoukr F, Wendum D, Couvelard A, Barbet J, Forgez P, Talbot JN, Gruaz-Guyon A. Prignon A, et al. Among authors: Forgez P. Mol Pharm. 2019 Jun 3;16(6):2776-2784. doi: 10.1021/acs.molpharmaceut.9b00283. Epub 2019 May 3. Mol Pharm. 2019. PMID: 31013092
Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer.
Liu J, Agopiantz M, Poupon J, Wu Z, Just PA, Borghese B, Ségal-Bendirdjian E, Gauchotte G, Gompel A, Forgez P. Liu J, et al. Among authors: Forgez P. Clin Cancer Res. 2017 Nov 1;23(21):6516-6528. doi: 10.1158/1078-0432.CCR-17-0861. Epub 2017 Aug 8. Clin Cancer Res. 2017. PMID: 28790113 Free article. Clinical Trial.
Glucocorticoid receptor and breast cancer.
Vilasco M, Communal L, Mourra N, Courtin A, Forgez P, Gompel A. Vilasco M, et al. Among authors: Forgez P. Breast Cancer Res Treat. 2011 Nov;130(1):1-10. doi: 10.1007/s10549-011-1689-6. Epub 2011 Aug 5. Breast Cancer Res Treat. 2011. PMID: 21818591 Review.
76 results
Jump to page
Feedback